Drugs that contain Ciclesonide
1. Drug name - ALVESCO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8371292 | COVIS | Use of ciclesonide for the treatment of respiratory diseases |
Feb, 2028
(5 years from now) | |
Treatment: Maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. patent claims method for treating a respiratory disease in a child
Dosage: AEROSOL, METERED;INHALATION
| Strength | Dosage | Availability |
|---|---|---|
| 0.08MG/INH | AEROSOL, METERED;INHALATION | Prescription |
| 0.16MG/INH | AEROSOL, METERED;INHALATION | Prescription |
2. Drug name - OMNARIS
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8371292 | COVIS | Use of ciclesonide for the treatment of respiratory diseases |
Feb, 2028
(5 years from now) | |
Treatment: Treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. treatment of nasal symptoms associated w perennial allergic rhinitis in adults and adolescents 12 years of age and older
Dosage: SPRAY, METERED;NASAL
| Strength | Dosage | Availability |
|---|---|---|
| 0.05MG/SPRAY | SPRAY, METERED;NASAL | Prescription |
3. Drug name - ZETONNA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8371292 | COVIS | Use of ciclesonide for the treatment of respiratory diseases |
Feb, 2028
(5 years from now) | |
Treatment: Treatment of symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. patent claims methods for treating a respiratory disease in a child
Dosage: AEROSOL, METERED;NASAL
| Strength | Dosage | Availability |
|---|---|---|
| 0.037MG/INH | AEROSOL, METERED;NASAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.